SCHEMBL6204871

SCHEMBL6204871

COC(O)c1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
CYP3A4 P08684 3/20 0.44
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
IDO1 P14902 2/20 0.40
TDO2 P48775 2/20 0.40
ALDH1A1 P00352 6/20 0.39
LMNA P02545 2/20 0.39
CYP2C9 P11712 2/20 0.38
GAA P10253 1/20 0.38
CYP2C19 P33261 1/20 0.38
MC4R P32245 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PKM P14618 1/20 0.36
HTT P42858 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18892781 0.84 GABRA1 (0.39) CYP3A4KMT2AALDH1A1LMNACYP2C9
SCHEMBL20386379 0.80 CES2 (0.34) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL25663412 0.80 CES2 (0.34) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL15087394 0.78 GAA (0.46) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL9019981 0.77 IDO1 (0.42) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL11602791 0.76 CES2 (0.54) CES2CES1CYP3A4MEN1KMT2A
SCHEMBL6204702 0.76 GABRA1 (0.48) CYP3A4KMT2ALMNA
SCHEMBL1755231 0.76 ESR1 (0.52) CYP3A4ALDH1A1LMNACYP2C9GAA
SCHEMBL6203758 0.76 CA1 (0.52) CYP3A4IDO1TDO2ALDH1A1LMNA
SCHEMBL467714 0.76 GABRA1 (0.54) CYP3A4ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed